| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/24/2002 | EP1223987A2 Method |
| 07/24/2002 | EP1223984A2 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 07/24/2002 | EP1223981A1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 07/24/2002 | EP1223980A2 Use of csf-1 inhibitors |
| 07/24/2002 | EP1223979A1 Adjuvants for nucleic acid vaccines |
| 07/24/2002 | EP1223978A2 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 07/24/2002 | EP1223977A2 Modified plant viruses and methods of use thereof |
| 07/24/2002 | EP1223976A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 07/24/2002 | EP1223975A2 MUCOSAL DTPa VACCINES |
| 07/24/2002 | EP1223974A2 Medicament in order to induce tolerance |
| 07/24/2002 | EP1223973A2 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 07/24/2002 | EP1223966A2 Use of gdnf for treating corneal defects |
| 07/24/2002 | EP1223965A2 Modulation of angiogenesis |
| 07/24/2002 | EP1223964A1 April receptor (bcma) and uses thereof |
| 07/24/2002 | EP1223963A2 T-cells and molecules involved in immune regulation |
| 07/24/2002 | EP1223962A1 Method and compositions for inhibiting adhesion formation |
| 07/24/2002 | EP1223961A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 07/24/2002 | EP1223956A1 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 07/24/2002 | EP1223915A1 Dry powder compositions having improved dispersivity |
| 07/24/2002 | EP0826001B1 Acellular pertussis vaccines and methods of preparation thereof |
| 07/24/2002 | EP0800579B1 Combination gene delivery vehicles |
| 07/24/2002 | EP0733643B1 Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor |
| 07/24/2002 | EP0719340B1 Cloned glutamic acid decarboxylase |
| 07/24/2002 | EP0693183B1 Methods for diabetes susceptibility assessment in asymptomatic patients |
| 07/24/2002 | EP0579640B1 Glial mitogenic factors, their preparation and use |
| 07/24/2002 | CN1360678A Early detection of flaviviruses using NS1 glycoprotein |
| 07/24/2002 | CN1360638A Recombinant protein production in human cell using sequences encoding adenovirus E1 protein |
| 07/24/2002 | CN1360629A Induction of vascular endothelial growth factor (VEGF) by serine/threonine protein kinase AKT |
| 07/24/2002 | CN1360628A Method for transfer of antigens to dendritic cells |
| 07/24/2002 | CN1360596A Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 07/24/2002 | CN1360595A Immunogenic peptides derived from MAGE and use thereof |
| 07/24/2002 | CN1360594A Attenuated microorganisms for treatment of infection |
| 07/24/2002 | CN1360507A Conjugates and method for production thereof, and their use for transporting molecules via biological membranes |
| 07/24/2002 | CN1087953C Vaccine design and production |
| 07/23/2002 | US6423837 Epitopes; diagnosis; gene expression vectors |
| 07/23/2002 | US6423836 Production and use of human nm23 protein and antibodies therefor |
| 07/23/2002 | US6423545 Unmarked deletion mutants of mycobacteria and methods of using same |
| 07/23/2002 | US6423542 Oligonucleotide mediated nucleic acid recombination |
| 07/23/2002 | US6423539 Enhancing immunology response |
| 07/23/2002 | US6423528 Herpes simplex virus-1 strain 17, genome of which is modified in specified terminal portion such that strain lacks neurovirulence |
| 07/23/2002 | US6423527 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 07/23/2002 | US6423507 Detecting enzyme inhibitors; obtain protease, incubate with modulator, monitor adjustment in protease activity |
| 07/23/2002 | US6423500 Mammalian receptors for interleukin-10 |
| 07/23/2002 | US6423496 Nucleotide sequences for use in the detection, diagnosis and monitoring of mammary gland tumors |
| 07/23/2002 | US6423319 Methods for treating muscle injuries |
| 07/23/2002 | US6423318 Hepatitis A virus vaccines |
| 07/23/2002 | US6423313 Inhibition of tumor growth by blockade of the protein C system |
| 07/23/2002 | CA2368791A1 Medicament for the protection against thrombotic diseases |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2168440C Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
| 07/23/2002 | CA2091769C Framework mutated antibodies and their preparation |
| 07/23/2002 | CA2074720C Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 07/23/2002 | CA2072642C Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
| 07/23/2002 | CA2066221C Conjugate vaccine for group b streptococcus |
| 07/23/2002 | CA2051092C Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions |
| 07/23/2002 | CA2042503C Novel bifunctional linking compounds, conjugates and methods for their production |
| 07/18/2002 | WO2002056027A2 Regulation of neutral development by daedalos |
| 07/18/2002 | WO2002055713A2 58848, a human protein kinase family member and uses therefor |
| 07/18/2002 | WO2002055706A2 Asip-related proteins |
| 07/18/2002 | WO2002055705A2 Proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055702A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 07/18/2002 | WO2002055695A1 Human glioma antigen and process for preparing the same |
| 07/18/2002 | WO2002055676A2 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 07/18/2002 | WO2002055675A1 Ancillary composition for the preparation of committed mature dendritic cells |
| 07/18/2002 | WO2002055663A2 Srebp pathway modulation through targeting hisrs |
| 07/18/2002 | WO2002055560A2 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c |
| 07/18/2002 | WO2002055555A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | WO2002055552A2 Soluble cyclic analogues of beta amyloid peptide |
| 07/18/2002 | WO2002055549A2 Systems for expression of heterologous proteins in m. capsulatus |
| 07/18/2002 | WO2002055548A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/18/2002 | WO2002055539A1 Process to concentrate insoluble proteins by vibrating membrane filtration |
| 07/18/2002 | WO2002055533A2 Methods of using imxp-888 and imxp-888 antagonists |
| 07/18/2002 | WO2002055485A1 Prodrugs of excitatory amino acids |
| 07/18/2002 | WO2002055106A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 07/18/2002 | WO2002055105A1 Manufacturing method of combined vaccine |
| 07/18/2002 | WO2002055104A2 Acne vaccine |
| 07/18/2002 | WO2002055103A1 Tumor vaccines |
| 07/18/2002 | WO2002055100A2 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 07/18/2002 | WO2002055010A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/18/2002 | WO2002034205A3 Using heat shock proteins to increase immune response |
| 07/18/2002 | WO2002031025A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/18/2002 | WO2002030458A8 Yersinia adhesion protein as vaccine adjuvant |
| 07/18/2002 | WO2002029088A3 Highly expressible genes |
| 07/18/2002 | WO2002028418B1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 07/18/2002 | WO2002028414B1 Compositions and methods for wt1 specific immunotherapy |
| 07/18/2002 | WO2002028351A3 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 07/18/2002 | WO2002022159A8 Thionin as an antineoplastic and immunostimulant |
| 07/18/2002 | WO2002016549A3 METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE |
| 07/18/2002 | WO2002016431A3 PEPTIDES OF THE α1-ADRENERGIC RECEPTOR AND THEIR USE FOR PSORIASIS |
| 07/18/2002 | WO2002013856A3 W/o emulsion adjuvant compositions for vaccines |
| 07/18/2002 | WO2002013758A3 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 07/18/2002 | WO2002012535B1 Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy |
| 07/18/2002 | WO2002004522A3 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 07/18/2002 | WO2002002143A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 07/18/2002 | WO2001094551A3 Genetically modified t-cells, method for producing them and use thereof |
| 07/18/2002 | WO2001088132A3 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 07/18/2002 | WO2001085798A3 Human monoclonal antibodies to dendritic cells |
| 07/18/2002 | WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 07/18/2002 | WO2001083749A3 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 07/18/2002 | WO2001079282A3 Molecules associated with human reproduction |